Skip to main content
Top
Published in: Current Allergy and Asthma Reports 11/2014

01-11-2014 | Pediatric Allergy and Immunology (JM Portnoy and CE Ciaccio, Section Editors)

Empowering the Child and Caregiver: Yellow Zone Asthma Action Plan

Authors: Chitra Dinakar, Jay M. Portnoy

Published in: Current Allergy and Asthma Reports | Issue 11/2014

Login to get access

Abstract

Current guidelines, both national and international, elegantly describe evidence-based measures to attain and maintain long-term control of asthma. These strategies, typically discussed between the provider and patient, are provided in the form of written (or electronic) instructions as part of the green zone of the color-coded Asthma Action Plan. The red zone of the Asthma Action Plan has directives on when to use systemic corticosteroids and seek medical attention. The transition zone between the green zone of good control and the red zone of asthma exacerbation is the yellow zone. This zone guides the patient on self-management of exacerbations outside a medical setting. Unfortunately, the only recommendation currently available to patients per the current asthma guidelines is the repetitive use of reliever bronchodilators. This approach, while providing modest symptom relief, does not reliably prevent progression to the red zone. In this document, we present new, evidence-based, yellow zone intervention options.
Literature
1.
go back to reference Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2003;1, CD001117. doi:10.1002/14651858.CD001117.PubMed Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P, et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev. 2003;1, CD001117. doi:10.​1002/​14651858.​CD001117.PubMed
4.••
go back to reference Dinakar C, Oppenheimer J, Portnoy J, Bacharier LB, Li J, Kercsmar CM, et al. Management of acute loss of asthma control in the yellow zone: a practice parameter. Ann Allergy Asthma Immunol. 2014;113(2):143–59. A ground-breaking practice parameter critically reviewing pharmacological interventions for the management of yellow zone (home) exacerbations of asthma, exposing missing gaps in current recommendations, and suggesting evidence-based options. Dinakar C, Oppenheimer J, Portnoy J, Bacharier LB, Li J, Kercsmar CM, et al. Management of acute loss of asthma control in the yellow zone: a practice parameter. Ann Allergy Asthma Immunol. 2014;113(2):143–59. A ground-breaking practice parameter critically reviewing pharmacological interventions for the management of yellow zone (home) exacerbations of asthma, exposing missing gaps in current recommendations, and suggesting evidence-based options.
6.
7.••
go back to reference Beigelman A, King TS, Mauger D, Zeiger RS, Strunk RC, Kelly HW, et al. Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing? J Allergy Clin Immunol. 2013;131(6):1518–25. doi:10.1016/j.jaci.2013.01.034. A provocative study that questions the widely-accepted belief that oral corticosteroids reliably influence outcomes in preschool children with wheezing illnesses. Beigelman A, King TS, Mauger D, Zeiger RS, Strunk RC, Kelly HW, et al. Do oral corticosteroids reduce the severity of acute lower respiratory tract illnesses in preschool children with recurrent wheezing? J Allergy Clin Immunol. 2013;131(6):1518–25. doi:10.​1016/​j.​jaci.​2013.​01.​034. A provocative study that questions the widely-accepted belief that oral corticosteroids reliably influence outcomes in preschool children with wheezing illnesses.
8.
go back to reference Dolan LM, Kesarwala HH, Holroyde JC, Fischer TJ. Short-term, high-dose, systemic steroids in children with asthma: the effect on the hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol. 1987;80(1):81–7.PubMedCrossRef Dolan LM, Kesarwala HH, Holroyde JC, Fischer TJ. Short-term, high-dose, systemic steroids in children with asthma: the effect on the hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol. 1987;80(1):81–7.PubMedCrossRef
9.
go back to reference Kayani S, Shannon DC. Adverse behavioral effects of treatment for acute exacerbation of asthma in children: a comparison of two doses of oral steroids. Chest. 2002;122(2):624–8.PubMedCrossRef Kayani S, Shannon DC. Adverse behavioral effects of treatment for acute exacerbation of asthma in children: a comparison of two doses of oral steroids. Chest. 2002;122(2):624–8.PubMedCrossRef
11.••
go back to reference Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13. doi:10.1186/1471-2466-6-13. An eye-opening study that enlightens providers regarding the self-expressed confidence of patients to recognize impending exacerbations and up-regulate their asthma medications, including controllers, during periods of worsening symptoms. Partridge MR, van der Molen T, Myrseth SE, Busse WW. Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study. BMC Pulm Med. 2006;6:13. doi:10.​1186/​1471-2466-6-13. An eye-opening study that enlightens providers regarding the self-expressed confidence of patients to recognize impending exacerbations and up-regulate their asthma medications, including controllers, during periods of worsening symptoms.
12.•
go back to reference Dinakar C, Van Osdol TJ, Wible K. How frequent are asthma exacerbations in a pediatric primary care setting and do written asthma action plans help in their management? J Asthma Offi J Assoc Care Asthma. 2004;41(8):807–12. This study affirms the belief that patients with asthma like to be empowered with asthma plans containing well-written and clear instructions on managing asthma. Dinakar C, Van Osdol TJ, Wible K. How frequent are asthma exacerbations in a pediatric primary care setting and do written asthma action plans help in their management? J Asthma Offi J Assoc Care Asthma. 2004;41(8):807–12. This study affirms the belief that patients with asthma like to be empowered with asthma plans containing well-written and clear instructions on managing asthma.
13.
go back to reference Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med. 2004;170(8):836–44.PubMedCrossRef Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med. 2004;170(8):836–44.PubMedCrossRef
14.
go back to reference FitzGerald JM, Becker A, Sears MR, Mink S, Chung K, Lee J. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax. 2004;59(7):550–6.PubMedCrossRefPubMedCentral FitzGerald JM, Becker A, Sears MR, Mink S, Chung K, Lee J. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax. 2004;59(7):550–6.PubMedCrossRefPubMedCentral
15.••
go back to reference Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O’Byrne PM, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med. 1999;160(2):594–9. This ageless study provides invaluable information on the chronology and kinetics of an asthma exacerbation. Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer CA, O’Byrne PM, et al. Exacerbations of asthma: a descriptive study of 425 severe exacerbations. The FACET International Study Group. Am J Respir Crit Care Med. 1999;160(2):594–9. This ageless study provides invaluable information on the chronology and kinetics of an asthma exacerbation.
16.
go back to reference Strunk RC, Sternberg AL, Bacharier LB, Szefler SJ. Nocturnal awakening caused by asthma in children with mild-to-moderate asthma in the childhood asthma management program. J Allergy Clin Immunol. 2002;110(3):395–403.PubMedCrossRef Strunk RC, Sternberg AL, Bacharier LB, Szefler SJ. Nocturnal awakening caused by asthma in children with mild-to-moderate asthma in the childhood asthma management program. J Allergy Clin Immunol. 2002;110(3):395–403.PubMedCrossRef
17.
go back to reference Harrison TW, Oborne J, Newton S, Tattersfield AE. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet. 2004;363(9405):271–5.PubMedCrossRef Harrison TW, Oborne J, Newton S, Tattersfield AE. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet. 2004;363(9405):271–5.PubMedCrossRef
18.
19.
go back to reference Ducharme FM, Lemire C, Noya FJ, Davis GM, Alos N, Leblond H, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med. 2009;360(4):339–53. doi:10.1056/NEJMoa0808907.PubMedCrossRef Ducharme FM, Lemire C, Noya FJ, Davis GM, Alos N, Leblond H, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med. 2009;360(4):339–53. doi:10.​1056/​NEJMoa0808907.PubMedCrossRef
20.
go back to reference Van Metre Jr TE, Marsh DG, Adkinson Jr NF, Fish JE, Kagey-Sobotka A, Norman PS, et al. Dose of cat (Felis domesticus) allergen 1 (Fel d 1) that induces asthma. J Allergy Clin Immunol. 1986;78(1 Pt 1):62–75.PubMed Van Metre Jr TE, Marsh DG, Adkinson Jr NF, Fish JE, Kagey-Sobotka A, Norman PS, et al. Dose of cat (Felis domesticus) allergen 1 (Fel d 1) that induces asthma. J Allergy Clin Immunol. 1986;78(1 Pt 1):62–75.PubMed
21.
go back to reference Covar RA, Szefler SJ, Zeiger RS, Sorkness CA, Moss M, Mauger DT, et al. Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. J Allergy Clin Immunol. 2008;122(4):741–7 e4.PubMedCrossRefPubMedCentral Covar RA, Szefler SJ, Zeiger RS, Sorkness CA, Moss M, Mauger DT, et al. Factors associated with asthma exacerbations during a long-term clinical trial of controller medications in children. J Allergy Clin Immunol. 2008;122(4):741–7 e4.PubMedCrossRefPubMedCentral
22.
go back to reference Thomas A, Lemanske RF, Jr., Jackson DJ. Approaches to stepping up and stepping down care in asthmatic patients. J Allergy Clin Immunol. 128(5):915–24; quiz 25–6. Thomas A, Lemanske RF, Jr., Jackson DJ. Approaches to stepping up and stepping down care in asthmatic patients. J Allergy Clin Immunol. 128(5):915–24; quiz 25–6.
23.
go back to reference National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. Expert Panel Report 2, National Institutes of Health, Bethesda, MD. 1997. National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. Expert Panel Report 2, National Institutes of Health, Bethesda, MD. 1997.
24.••
go back to reference Blake K, Madabushi R, Derendorf H, Lima J. Population pharmacodynamic model of bronchodilator response to inhaled albuterol in children and adults with asthma. Chest. 2008;134(5):981–9. This study provides reassurance on the commonly used doses of inhaled short acting beta2 agonists used to treat asthma symptoms. Blake K, Madabushi R, Derendorf H, Lima J. Population pharmacodynamic model of bronchodilator response to inhaled albuterol in children and adults with asthma. Chest. 2008;134(5):981–9. This study provides reassurance on the commonly used doses of inhaled short acting beta2 agonists used to treat asthma symptoms.
25.
go back to reference Schuh S, Johnson DW, Stephens D, Callahan S, Winders P, Canny GJ. Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma. J Pediatr. 1999;135(1):22–7.PubMedCrossRef Schuh S, Johnson DW, Stephens D, Callahan S, Winders P, Canny GJ. Comparison of albuterol delivered by a metered dose inhaler with spacer versus a nebulizer in children with mild acute asthma. J Pediatr. 1999;135(1):22–7.PubMedCrossRef
26.
go back to reference Wilson NM, Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child. 1990;65(4):407–10.PubMedCrossRefPubMedCentral Wilson NM, Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child. 1990;65(4):407–10.PubMedCrossRefPubMedCentral
28.
go back to reference Volovitz B, Nussinovitch M, Finkelstein Y, Harel L, Varsano I. Effectiveness of inhaled corticosteroids in controlling acute asthma exacerbations in children at home. Clin Pediatr. 2001;40(2):79–86.CrossRef Volovitz B, Nussinovitch M, Finkelstein Y, Harel L, Varsano I. Effectiveness of inhaled corticosteroids in controlling acute asthma exacerbations in children at home. Clin Pediatr. 2001;40(2):79–86.CrossRef
30.••
go back to reference Foresi A, Morelli MC, Catena E, On behalf of the Italian Study Group. Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. Chest. 2000;117(2):440–6. A pivotal study indicating the effectiveness of the strategy of quadrupling inhaled corticosteroids for controlling asthma exacerbations (yellow zone). Foresi A, Morelli MC, Catena E, On behalf of the Italian Study Group. Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. Chest. 2000;117(2):440–6. A pivotal study indicating the effectiveness of the strategy of quadrupling inhaled corticosteroids for controlling asthma exacerbations (yellow zone).
31.••
go back to reference Oborne J, Mortimer K, Hubbard RB, Tattersfield AE, Harrison TW. Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial. Am J Respir Crit Care Med. 2009;180(7):598–602. doi:10.1164/rccm.200904-0616OC. Per protocol analysis in this study demonstrated effectiveness of quadrupling of inhaled corticosteroids in treating early asthma exacerbations. Oborne J, Mortimer K, Hubbard RB, Tattersfield AE, Harrison TW. Quadrupling the dose of inhaled corticosteroid to prevent asthma exacerbations: a randomized, double-blind, placebo-controlled, parallel-group clinical trial. Am J Respir Crit Care Med. 2009;180(7):598–602. doi:10.​1164/​rccm.​200904-0616OC. Per protocol analysis in this study demonstrated effectiveness of quadrupling of inhaled corticosteroids in treating early asthma exacerbations.
32.
go back to reference Yousef E, Hossain J, Mannan S, Skorpinski E, McGeady S. Early intervention with high-dose inhaled corticosteroids for control of acute asthma exacerbations at home and improved outcomes: a randomized controlled trial. Allergy Asthma Proc. 2012;33(6):508–13.PubMedCrossRef Yousef E, Hossain J, Mannan S, Skorpinski E, McGeady S. Early intervention with high-dose inhaled corticosteroids for control of acute asthma exacerbations at home and improved outcomes: a randomized controlled trial. Allergy Asthma Proc. 2012;33(6):508–13.PubMedCrossRef
33.
go back to reference Toogood JH, Baskerville JC, Jennings B, Lefcoe NM, Johansson SA. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol. 1982;70(4):288–98.PubMedCrossRef Toogood JH, Baskerville JC, Jennings B, Lefcoe NM, Johansson SA. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol. 1982;70(4):288–98.PubMedCrossRef
34.••
go back to reference Boushey HA, Sorkness CA, King TS, Sullivan SD, Fahy JV, Lazarus SC, et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med. 2005;352(15):1519–28. doi:10.1056/NEJMoa042552. A landmark study exploring the notion of piggy-backing anti-inflammatory inhaled steroid medication with rescue short-acting beta agonist use in the management of well-controlled, mild persistent asthma. Boushey HA, Sorkness CA, King TS, Sullivan SD, Fahy JV, Lazarus SC, et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med. 2005;352(15):1519–28. doi:10.​1056/​NEJMoa042552. A landmark study exploring the notion of piggy-backing anti-inflammatory inhaled steroid medication with rescue short-acting beta agonist use in the management of well-controlled, mild persistent asthma.
35.
go back to reference Papi A, Canonica GW, Maestrelli P, Paggiaro P, Olivieri D, Pozzi E, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med. 2007;356(20):2040–52.PubMedCrossRef Papi A, Canonica GW, Maestrelli P, Paggiaro P, Olivieri D, Pozzi E, et al. Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. N Engl J Med. 2007;356(20):2040–52.PubMedCrossRef
36.••
go back to reference Martinez FD, Chinchilli VM, Morgan WJ, Boehmer SJ, Lemanske RF, Jr., Mauger DT et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet. 377(9766):650–7. An important study validating the coupling anti-inflammatory inhaled steroid medication with rescue short-acting beta agonist use in the management of well-controlled, mild persistent asthma in children. Martinez FD, Chinchilli VM, Morgan WJ, Boehmer SJ, Lemanske RF, Jr., Mauger DT et al. Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. Lancet. 377(9766):650–7. An important study validating the coupling anti-inflammatory inhaled steroid medication with rescue short-acting beta agonist use in the management of well-controlled, mild persistent asthma in children.
37.
go back to reference Calhoun WJ, Ameredes BT, King TS, Icitovic N, Bleecker ER, Castro M et al. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. JAMA. 308(10):987–97. Calhoun WJ, Ameredes BT, King TS, Icitovic N, Bleecker ER, Castro M et al. Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial. JAMA. 308(10):987–97.
38.
go back to reference Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet. 2006;368(9537):744–53. doi:10.1016/S0140-6736(06)69284-2.PubMedCrossRef Rabe KF, Atienza T, Magyar P, Larsson P, Jorup C, Lalloo UG. Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet. 2006;368(9537):744–53. doi:10.​1016/​S0140-6736(06)69284-2.PubMedCrossRef
39.
go back to reference O’Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005;171(2):129–36. doi:10.1164/rccm.200407-884OC.PubMedCrossRef O’Byrne PM, Bisgaard H, Godard PP, Pistolesi M, Palmqvist M, Zhu Y, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med. 2005;171(2):129–36. doi:10.​1164/​rccm.​200407-884OC.PubMedCrossRef
40.
go back to reference Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, et al. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin. 2004;20(9):1403–18. doi:10.1185/030079904X2051.PubMedCrossRef Scicchitano R, Aalbers R, Ukena D, Manjra A, Fouquert L, Centanni S, et al. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin. 2004;20(9):1403–18. doi:10.​1185/​030079904X2051.PubMedCrossRef
42.••
go back to reference Cates CJ, Karner C. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database Syst Rev. 2013;4:CD007313. doi:10.1002/14651858.CD007313.pub3. An evidence-based review validating the effectiveness of the adjustable maintenance dosing strategy in ensuring maintenance of asthma control in adults. Cates CJ, Karner C. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children. Cochrane Database Syst Rev. 2013;4:CD007313. doi:10.​1002/​14651858.​CD007313.​pub3. An evidence-based review validating the effectiveness of the adjustable maintenance dosing strategy in ensuring maintenance of asthma control in adults.
45.••
go back to reference Bisgaard H, Le Roux P, Bjamer D, Dymek A, Vermeulen JH, Hultquist C. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest. 2006;130(6):1733–43. doi:10.1378/chest.130.6.1733. An important study exploring the role of adjustable maintenance therapy in the management of children with asthma. Bisgaard H, Le Roux P, Bjamer D, Dymek A, Vermeulen JH, Hultquist C. Budesonide/formoterol maintenance plus reliever therapy: a new strategy in pediatric asthma. Chest. 2006;130(6):1733–43. doi:10.​1378/​chest.​130.​6.​1733. An important study exploring the role of adjustable maintenance therapy in the management of children with asthma.
46.••
go back to reference Cates CJ, Lasserson TJ. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database Syst Rev. 2010;(1):CD007694. doi:10.1002/14651858.CD007694.pub2. An insightful critical appraisal of safety issues related to the use of combination therapy in asthma management. Cates CJ, Lasserson TJ. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database Syst Rev. 2010;(1):CD007694. doi:10.​1002/​14651858.​CD007694.​pub2. An insightful critical appraisal of safety issues related to the use of combination therapy in asthma management.
47.
go back to reference Leuppi JD, Downie SR, Salome CM, Jenkins CR, Woolcock AJ. A single high dose of inhaled corticosteroids: a possible treatment of asthma exacerbations. Swiss Med Wkly. 2002;132(1–2):7–11.PubMed Leuppi JD, Downie SR, Salome CM, Jenkins CR, Woolcock AJ. A single high dose of inhaled corticosteroids: a possible treatment of asthma exacerbations. Swiss Med Wkly. 2002;132(1–2):7–11.PubMed
49.
go back to reference Karpel JP, Schacter EN, Fanta C, Levey D, Spiro P, Aldrich T, et al. A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma. Chest. 1996;110(3):611–6.PubMedCrossRef Karpel JP, Schacter EN, Fanta C, Levey D, Spiro P, Aldrich T, et al. A comparison of ipratropium and albuterol vs albuterol alone for the treatment of acute asthma. Chest. 1996;110(3):611–6.PubMedCrossRef
50.
Metadata
Title
Empowering the Child and Caregiver: Yellow Zone Asthma Action Plan
Authors
Chitra Dinakar
Jay M. Portnoy
Publication date
01-11-2014
Publisher
Springer US
Published in
Current Allergy and Asthma Reports / Issue 11/2014
Print ISSN: 1529-7322
Electronic ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-014-0475-z

Other articles of this Issue 11/2014

Current Allergy and Asthma Reports 11/2014 Go to the issue

OTITIS (DP SKONER, SECTION EDITOR)

Role of Obesity in Otitis Media in Children

IMMUNOTHERAPY AND IMMUNOMODULATORS (L COX, SECTION EDITOR)

Immune Mechanisms of Sublingual Immunotherapy

ALLERGIC SKIN DISEASES (L FONACIER, SECTION EDITOR)

Hand Dermatitis: an Allergist’s Nightmare

ANAPHYLAXIS AND DRUG ALLERGY (DA KHAN AND M CASTELLS, SECTION EDITORS)

Penicillin and Beta-Lactam Allergy: Epidemiology and Diagnosis